BioNova Announces First Patient Dosed in a Phase 1/2 Study of BN301 for the Treatment of Hematologic Malignancies in China Download SHANGHAI, China, February. 9, 2023 – BioNova Pharmaceuticals Limited (BioNova), a company dedicated to the discovery, development...
Sutro Biopharma
310 Utah Ave
Suite 150
South San Francisco, CA 94080
650.392.8412
